Nisa Investment Advisors, LLC Pacira Bio Sciences, Inc. Transaction History
Nisa Investment Advisors, LLC
- $29.3 Billion
- Q4 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,869 shares of PCRX stock, worth $44,444. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,869
Previous 2,294
18.53%
Holding current value
$44,444
Previous $59,000
25.42%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding PCRX
# of Institutions
263Shares Held
49.3MCall Options Held
118KPut Options Held
63.7K-
Black Rock Inc. New York, NY8.01MShares$190 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$124 Million0.0% of portfolio
-
Doma Perpetual Capital Management LLC Miami, FL2.7MShares$64.2 Million23.38% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$51.4 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.14MShares$50.8 Million0.08% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.09B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...